Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer

BACKGROUND: Adjuvant chemotherapy is recommended in high-risk breast cancer. However, no universally accepted guidelines exist on pre-chemotherapy assessment. In particular, the number and frequency of medical visits vary according to each institution’s policy. We hypothesised that the Edmonton Symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanna, Valeria, Fedele, Palma, Deiana, Giulia, Alicicco, Maria G, Ninniri, Chiara, Santoro, Anna N, Pazzola, Antonio, Fancellu, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Control Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346425/
https://www.ncbi.nlm.nih.gov/pubmed/36157162
http://dx.doi.org/10.5306/wjco.v13.i7.577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346425/
https://www.ncbi.nlm.nih.gov/pubmed/36157162
http://dx.doi.org/10.5306/wjco.v13.i7.577

Ejemplares similares